CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH BEPRIDIL
Heteromer 32-632
3×NAG; 12×NAG; 15×GOL; 9×DMS; 3×CQN; Assess CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH SERTRALINE
Heteromer 32-632
3×NAG; 12×NAG; 15×GOL; 3×SRE; 3×DMS; Assess CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH benztropine
Heteromer 32-632
15×NAG; 15×GOL; 6×CXQ; 39×DMS; Assess CRYSTAL STRUCTURE OF EBOLAVIRUS GLYCOPROTEIN IN COMPLEX WITH PAROXETINE
Heteromer 32-632
3×NAG; 12×NAG; 3×DMS; 15×GOL; 3×8PR; Assess Crystal structure of Ebola glycoprotein in complex with ibuprofen
Heteromer 32-632
3×NAG; 12×NAG; 15×GOL; 3×IBP; Assess Crystal structure of Ebola glycoprotein in complex with toremifene
Heteromer 32-632
3×NAG; 12×NAG; 6×GOL; 3×DMS; 3×T0R; Assess Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118
Heteromer 32-631
3×NAG; 15×NAG; 9×GOL; 6×GON; 3×DMS; Assess Crystal structure of Ebola glycoprotein
Heteromer 32-631
3×NAG; 15×NAG; 6×GOL; Assess Crystal structure of Ebolavirus glycoprotein in complex with imipramine
Heteromer 32-631
3×NAG; 12×NAG; 18×GOL; 6×IXX; 9×DMS; Assess Crystal structure of Ebolavirus glycoprotein in complex with inhibitor 118a
Heteromer 32-631
3×NAG; 15×NAG; 12×GOL; 6×GKZ; 3×DMS; Assess EM structure of a EBOV-GP bound to 4M0368 neutralizing antibody
Heteromer 32-631
3×NAG; 3×NAG; Assess EM structure of a EBOV-GP bound to 3T0331 neutralizing antibody
Heteromer 32-631
3×NAG; 3×MAN; 3×NAG; Assess Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075146
Heteromer 32-629
3×NAG; 12×NAG; 3×YOD; 6×GOL; Assess Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075231
Heteromer 32-628
3×NAG; 12×NAG; 3×ZQH; 3×EDO; 6×ACT; Assess Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075093
Heteromer 32-626
3×NAG; 12×NAG; 3×EDO; 6×ACT; 3×ZTL; Assess Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0074953
Heteromer 32-622
3×NAG; 12×NAG; 3×YPS; Assess Crystal Structure of Ebola zaire Envelope glycoprotein GP in complex with compound ARN0075164
Heteromer 32-622
3×NAG; 12×NAG; 9×EDO; 3×YPM; Assess Crystal structure of Ebola Zaire envelope glycoprotein GP in complex with compound ARN75092
Heteromer 32-618
3×NAG; 12×NAG; 3×XJ5; 3×GOL; Assess Crystal Structure of Ebola zaire GP protein with bound ARN0074898
Heteromer 32-618
3×NAG; 12×NAG; 15×GOL; 3×KHG; Assess Ebola virus glycoprotein in complex with EBOV-520 Fab
Heteromer 32-615
3×NAG; 3×GOL; Assess Structural Basis for Broad Neutralization of Ebolaviruses by an Antibody Targeting the Glycoprotein…
Heteromer 32-614
1×NAG; 2×NAG; Assess EBOV GP in complex with variable Fab domains of IgGs c4G7 and c13C6
Heteromer 33-615
3×NAG; 3×NAG; 3×NAG; Assess EBOV GP in complex with variable Fab domains of IgGs c2G4 and c13C6
Heteromer 33-615
3×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; Assess Structure of the Inmazeb cocktail and resistance to escape against Ebola virus
Heteromer 32-613
3×NAG; 8×NAG; Assess Structure of EBOV GPcl in complex with the pan-ebolavirus mAb ADI-15878
Heteromer 32-612
1×NAG; 2×NAG; 1×NAG; 2×NAG; Assess Structure of ZEBOV GP in complex with 3T0265 antibody
Heteromer 32-612
3×NAG; Assess Structure of ZEBOV GP in complex with 5T0180 antibody
Heteromer 32-612
3×NAG; Assess Structure of ZEBOV GP in complex with 1T0227 antibody
Heteromer 32-612
3×NAG; Assess BDBV-289 bound to EBOV GPdMuc Makona
Heteromer 32-612
3×NAG; 9×NAG; Assess Cleaved Ebola GP in complex with a broadly neutralizing human antibody, ADI-15946
Heteromer 32-611
2×NAG; 1×NAG; Assess Crystal structure of the trimeric prefusion Ebola virus glycoprotein in complex with a neutralizing…
Heteromer 32-599
2×NAG; 2×NAG; 1×NAG; 1×NAG; Assess Crystal Structure of Protective Human Antibodies 100 and 114 in Complex with Ebola Virus Fusion Gly…
Heteromer 33-599
Assess Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-296 and EBOV-515
Heteromer 32-598
3×NAG; 9×NAG; Assess EBOV GP bound to rEBOV-442 and rEBOV-515 Fabs
Heteromer 32-598
6×NAG; 3×NAG; 6×NAG; Assess Structure of EBOV GP lacking the mucin-like domain with 1C11 scFv and 1C3 Fab bound
Heteromer 33-599
3×NAG; Assess Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-293
Heteromer 32-598
3×NAG; 3×NAG; 6×NAG; Assess Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-442
Heteromer 32-598
6×NAG; 3×NAG; 6×NAG; Assess Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-437
Heteromer 32-597
3×NAG; 3×NAG; 9×NAG; Assess Structure of EBOV GP lacking the mucin-like domain with 2.1.1D5 scFv and 6D6 scFv bound
Heteromer 33-598
3×NAG; 3×NAG; Assess Structure of EBOV GP lacking the mucin-like domain with 9.20.1A2 Fab and 6D6 scFv bound
Heteromer 33-598
3×NAG; 3×NAG; Assess EBOV sGP in complex with variable Fab domains of IgGs c13C6 and BDBV91
Heteromer 53-284
Assess Crystal structure of host-primed Ebola virus GP, GPcl.
HeteromerP87666 ; 32-189
3×NAG; Assess Crystal structure of EBOV glycoprotein with modified HR1c and HR2 stalk at 3.2 A resolution homo-6-mer 33-637
3×NAG; 3×NAG; 6×NAG; 3×PO4; Assess Crystal structure of Ebolavirus glycoprotein in complex with clomipramine homo-6-mer 32-631
3×NAG; 12×NAG; 12×GOL; 3×CXX; Assess Crystal structure of Ebolavirus glycoprotein in complex with thioridazine homo-6-mer 32-631
3×NAG; 12×NAG; 12×GOL; 9×DMS; 3×RTZ; Assess Crystal structure of EBOV glycoprotein with modified HR2 stalk at 2.3A resolution homo-6-mer 33-626
6×NAG; 3×NAG; 6×GOL; 3×NAG; 3×PO4; Assess Crystal Structure of Stabilized GP from Makona Variant of Ebola Virus homo-3-mer 33-620
3×NAG; 3×NAG; Assess CORE STRUCTURE OF GP2 FROM EBOLA VIRUS homo-3-mer 557-630
1×CL; Assess NMR Structure of the Complete Internal Fusion Loop from Ebolavirus GP2 at pH 5.5 monomer 507-560
Assess NMR Structure of the Complete Internal Fusion Loop from Ebolavirus GP2 at pH 7.0 monomer 507-560
Assess NMR Structure of the Complete Internal Fusion Loop mutant L529A/I544A from Ebolavirus GP2 at pH 5.5 monomer 507-560
Assess NMR Structure of Ebola fusion peptide in SDS micelles at pH 7 monomer 524-539
Assess